Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023

SELL
$8.36 - $11.37 $1.16 Million - $1.57 Million
-138,395 Reduced 21.2%
514,379 $4.55 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $1.61 Million - $1.92 Million
203,000 Added 45.13%
652,774 $5.95 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $752,000 - $1.31 Million
109,621 Added 32.23%
449,774 $3.63 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $1.88 Million - $2.41 Million
-256,272 Reduced 42.97%
340,153 $3.19 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $3.1 Million - $4 Million
392,466 Added 192.42%
596,425 $4.78 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $1.41 Million - $1.71 Million
-167,724 Reduced 45.13%
203,959 $1.99 Million
Q2 2021

Aug 11, 2021

SELL
$9.9 - $11.56 $2.53 Million - $2.96 Million
-255,737 Reduced 40.76%
371,683 $3.68 Million
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $5.3 Million - $6.57 Million
-512,923 Reduced 44.98%
627,420 $7.24 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $5.13 Million - $6.58 Million
596,332 Added 109.62%
1,140,343 $11 Million
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $1.75 Million - $2.59 Million
203,811 Added 59.91%
544,011 $4.9 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $2.76 Million - $4.46 Million
340,200 New
340,200 $4.2 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $4.14 Million - $5.32 Million
-265,845 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $1.51 Million - $2.47 Million
-103,400 Reduced 28.0%
265,845 $4.1 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $1.27 Million - $1.55 Million
-60,500 Reduced 14.08%
369,245 $7.95 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $1.23 Million - $1.81 Million
73,300 Added 20.56%
429,745 $10.5 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $5.95 Million - $7.87 Million
356,445 New
356,445 $6.09 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.